Literature DB >> 6645813

Enhanced serum cortisol response to 5-hydroxytryptophan in depression and mania.

H Y Meltzer, B Uberkoman-Wiita, A Robertson, B J Tricou, M Lowy.   

Abstract

The serum cortisol responses to D,L-5-hydroxytryptophan (5-HTP), 200 mg per oral, in unmedicated depressed and manic patients, were both significantly greater than that of normal controls. The cortisol response to 5-HTP in depressed patients was significantly correlated with ratings of specific symptoms of depression. It was also greater in non-psychotic than in psychotic depressed patients as well as in those manic or depressed patients who attempted suicide compared to those who had not. In view of evidence for decreased brain serotonergic activity in depression and perhaps mania, the results suggest at least some serotonin receptors may be supersensitive in some patients with affective disorders.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6645813     DOI: 10.1016/0024-3205(83)90164-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.

Authors:  E A Mueller; D L Murphy; T Sunderland
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Serotonin function in panic disorder: effect of 1-5-hydroxytryptophan in patients and controls.

Authors:  H G Westenberg; J A den Boer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.